Results 201 to 210 of about 12,537 (253)
Some of the next articles are maybe not open access.

Pharmacology of botulinum toxin

Journal of the American Academy of Dermatology, 2000
Botulinum toxin has a well-defined role among dermatologists for the treatment of facial wrinkling, brow position, and palmar and axillary hyperhidrosis.The purpose of this study is to educate dermatologists on the pharmacology of botulinum toxin.A retrospective review of the literature on botulinum toxin from 1962 to the present was conducted.
W, Huang, J A, Foster, A S, Rogachefsky
openaire   +2 more sources

Browlift with Botulinum Toxin

Dermatologic Surgery, 2000
Botulinum toxin has been used successfully for the treatment of hyperfunctional facial lines.To determine the alteration in brow position after botulinum toxin treatment of the brow depressor muscles.Eleven women, 30-60 years old, were treated. Prior to treatment, brow position was measured relative to the pupil.
W, Huang, A S, Rogachefsky, J A, Foster
openaire   +2 more sources

Botulinum Toxin

American Journal of Physical Medicine & Rehabilitation, 2004
In the United States, the popularity of botulinum toxins as agents to treat muscle hypertonia has grown significantly over the last decade, despite lack of approval from the Food and Drug Administration for the indication of spasticity. Botox (botulinum toxin type A) and Myobloc (botulinum toxin type B) are Food and Drug Administration-approved for ...
openaire   +2 more sources

Botulinum Toxin in Otorhinolaryngology

2014
Through its anticholinergic effect, botulinum toxin is a suitable therapeutic option for dysfunctions of the muscular and the autonomic nervous system.Beside the classical indications like facial hyperkinesis (i.e. blepharospasm, hemifacial spasm), the treatment of complex dystonias (oromandibular dystonia, spasmodic dystonia, cervical dystonia ...
S, Rohrbach, R, Laskawi
openaire   +2 more sources

Botulinum Toxin and Pain

2020
This chapter is focused on analgesic mechanism of action of botulinum toxin type A (BoNT-A) including the action beyond peripheral nerve endings. With the exception of the meninges and possibly urinary bladder, the presence of BoNT-A activity in the periphery, cleaving SNAP25 as a target molecule, up to now was not convincingly shown.
openaire   +2 more sources

Botulinum Toxin for Rhinitis

Current Allergy and Asthma Reports, 2016
Rhinitis is a common clinical entity. Besides nasal obstruction, itching, and sneezing, one of the most important symptoms of rhinitis is nasal hypersecretion produced by nasal glands and exudate from the nasal vascular bed. Allergic rhinitis is an IgE-mediated inflammatory reaction of nasal mucosa after exposure to environmental allergens.
Cengiz, Ozcan, Onur, Ismi
openaire   +2 more sources

Botulinum Toxin in Ophthalmology

Survey of Ophthalmology, 2007
Since its introduction into clinical medicine in 1980, botulinum toxin has become a major therapeutic drug with applications valuable to many medical sub-specialties. Its use was spearheaded in ophthalmology where its potential applications have expanded to cover a broad range of visually related disorders.
Jonathan J, Dutton, Amy M, Fowler
openaire   +2 more sources

Botulinum Toxin and Pregnancy

SKINmed: Dermatology for the Clinician, 2006
The overall use of botulinum toxin type A in cosmetic procedures continues to rise, and the incidental exposures of pregnant women to the drug can occur. The author describes 2 patients who received botulinum toxin type A injections during pregnancy.
openaire   +2 more sources

Botulinum toxin and the eye

Hospital Medicine, 2003
Botulinum toxin in ophthalmology is used to reduce the function of the eyelid muscles in spasms or therapeutically. Therapeutic and diagnostic use in strabismus is also discussed, along with the controversial treatment of nystagmus.
openaire   +2 more sources

Botulinum Toxin

Plastic and Reconstructive Surgery, 2002
Alan, Matarasso, Anand K, Deva
openaire   +2 more sources

Home - About - Disclaimer - Privacy